Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023
Jul 11, 2023•47 min•Ep. 295
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, Stefan Zeuzem, MD, discusses new data on viral hepatitis presented at EASL 2023, including:
- Hepatitis B virus
- Durability of response with bepirovirsen
- HBsAg loss with siRNA VIR-2218 combined with either VIR-3434 (novel monoclonal antibody) or pegIFN-alfa
- Hepatitis delta virus
- 96-week follow-up of immediate vs delayed bulevirtide
- Off-treatment response for lonafarnib + ritonavir ± pegIFN-alfa
- Safety and efficacy outcomes with siRNA JNJ-3989 + nucleos(t)ide analogue
- Hepatitis C virus
- Collaborative service at opiate substitution treatment clinic to improve linkage to care in Ireland
- Nurse-led test-and-treat program to increase screening and diagnosis at female prisons in the United Kingdom
- FIND-C study using machine learning to improve screening-to-diagnosis ratio using clinical factors and social determinants of health
Presenter:
Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany
Link to full program:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android